Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Czechia Germany Hungary Italy +4
  • Study on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn’s Disease and an Ileostomy

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Italy The Netherlands Poland Sweden
  • Study on the Effects of Ozanimod for Children with Moderate to Severe Crohn’s Disease Not Responding to Usual Treatments

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Hungary Poland Spain
  • Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia France Germany +8
  • Study on the Long-term Safety of Vedolizumab for Children with Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Poland
  • Study on Subcutaneous Infliximab for Patients with Ulcerative Colitis, Crohn’s Disease, or Unclassified Inflammatory Bowel Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium
  • Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia France Germany Hungary +9
  • Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +6
  • Study on the Effectiveness and Safety of Subcutaneous Infliximab for Patients with Active Crohn’s Disease or Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +16